When the lab of the Botswana Harvard AIDS Institute Partnership produced the first genetic sequence of the Omicron variant of the coronavirus in fall 2021, the world took notice. More recognition came last month when the lab was…
Because antibiotic resistance can threaten the success of treatments across a wide range of conditions, more work needs to be done to prevent it, according to Bill Hanage of Harvard Chan School.
Sydney Stanley, PhD ’23, researches infectious diseases with an eye toward improving the health of the world’s most vulnerable populations
Introducing an effective new tuberculosis vaccine in low- and middle-income countries could lead to billions of dollars in potential health and economic benefits, according to a modeling study led by Harvard Chan School.
Investing more financial resources to accelerate scientific progress toward an effective tuberculosis vaccine will save lives, fight antimicrobial resistance, advance health equity, improve economic growth, and bring a substantial return on investment, according to a new report.
Researchers have discovered a new form of altered drug susceptibility—dubbed antibiotic resilience—that enables Mycobacterium tuberculosis to survive antibiotic treatment.
Harvard Chan School's Nancy Krieger and colleagues have updated and broadened a project aimed at training people in how to track and monitor socially related disparities having to do with where a person lives.
PhD candidate Harim Won is developing a new type of antibiotic to address long-standing issues of lengthy treatments and drug resistance, using a new approach to turn a normal protein system in the bacterial cell against itself.
Many essential health services—including cancer and tuberculosis screenings, HIV testing, maternal health services, and child vaccinations—declined during the COVID-19 pandemic in poor and rich countries alike around the globe, according to a new study co-authored by Harvard Chan…
To mark World TB Day, March 24, Harvard Chan School's Sarah Fortune, a TB expert, discusses the state of the disease worldwide, obstacles to fighting it, and the latest research.